Andrew Nightingale

Andrew Nightingale has extensive work experience in the field of data science and bioinformatics. Andrew is currently working as an Associate Director Data Science at Bicycle Therapeutics since May 2021. Prior to that, they worked at EMBL-European Bioinformatics Institute (EBI) as a Bioinformatician from February 2012 to February 2021. Andrew also has experience as a Research Scientist at ProSpect Pharma Inc from April 2002 to November 2011, where they specialized in Biomolecular NMR and project leadership. Andrew started their career at GE Lifesciences as a Research Scientist in July 1997.

Andrew Nightingale obtained their PhD in Biochemistry Bioinformatics from the University of Leeds, where they studied from 1998 to 2002.